| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Organic Sales Growth | 3% (Q4 2025) | 4% (Q1 2026) | +100 bps acceleration |
| Volume Growth | ~0% (Q4 2025) | 1% (Q1 2026) | +100 bps to positive territory |
| Adjusted EPS Growth | 15% (Q4 2025) | 13% (Q1 2026) | -200 bps deceleration |
| Operating Income Margin (Organic) | 18.5% (Q4 2025) | 16.8% (Q1 2026) | +70 bps expansion year-over-year |
| Global High Tech Growth | 20%+ (Q4 2025) | 20%+ (Q1 2026) | Sustained momentum |
| Life Sciences Growth | 7% (Q4 2025) | 11% (Q1 2026) | +400 bps acceleration |
| Bioprocessing Growth | ~75% (2025 full year) | 100%+ (Q1 2026) | +25%+ acceleration |
| Pest Elimination Growth | 7% (Q4 2025) | 7% (Q1 2026) | Consistent momentum |
| Food & Beverage Growth | 5% (Q4 2025) | 5% (Q1 2026) | Sustained outperformance |
| Specialty Growth | 7% (Q4 2025) | 9% (Q1 2026) | +200 bps acceleration |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.